MACQUARIE GROUP LTD – Vertex Pharmaceuticals Incorporated Transaction History
MACQUARIE GROUP LTD portfolio value:
$259.80M
portfolio value
MACQUARIE GROUP LTD quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.84% | -35.87K shares | -3.15M | $289.54 | 897.30K |
| Q2 2022 | share | Increase | +232.26% | 652.32K shares | 189.66M | $281.79 | 933.17K |
| Q1 2022 | share | Decrease | -7.69% | -23.39K shares | 6.48M | $260.97 | 280.85K |
| Q4 2021 | share | Decrease | -77.47% | -1.04M shares | -178.15M | $222.45 | 304.25K |
| Q3 2021 | share | Decrease | -16.47% | -266.25K shares | -81.02M | $181.39 | 1.35M |
| Q2 2021 | share | Increase | +974.36% | 1.46M shares | 293.65M | $201.63 | 1.61M |
| Q1 2021 | share | Increase | +10.57% | 14.38K shares | 172K | $214.89 | 150.48K |
| Q4 2020 | share | Increase | +4.40% | 5.73K shares | -3.30M | $236.34 | 136.10K |
| Q3 2020 | share | Increase | +17.52% | 19.43K shares | 3.27M | $272.12 | 130.36K |
| Q2 2020 | share | Increase | +1.66% | 1.80K shares | 6.23M | $290.31 | 110.92K |
| Q1 2020 | share | Decrease | -12.09% | -15.00K shares | -1.21M | $237.95 | 109.12K |
| Q4 2019 | share | Decrease | -11.11% | -15.51K shares | 3.52M | $218.95 | 124.12K |
| Q3 2019 | share | Increase | +2.23% | 3.05K shares | -1.39M | $169.42 | 139.64K |
| Q2 2019 | share | Decrease | -12.33% | -19.21K shares | -3.61M | $183.38 | 136.59K |
| Q1 2019 | share | Decrease | -2.22% | -3.54K shares | 2.25M | $183.95 | 155.81K |
| Q4 2018 | share | Increase | +3.72% | 5.71K shares | -3.20M | $165.71 | 159.35K |
| Q3 2018 | share | Decrease | -8.07% | -13.49K shares | 1.20M | $192.74 | 153.63K |
| Q2 2018 | share | Decrease | -7.53% | -13.60K shares | -1.05M | $169.96 | 167.12K |
| Q1 2018 | share | Increase | +7.40% | 12.45K shares | 4.59M | $162.98 | 180.73K |
| Q4 2017 | share | Decrease | -24.97% | -56.00K shares | -9.23M | $149.86 | 168.27K |
| Q3 2017 | share | Increase | +8.16% | 16.92K shares | 7.37M | $152.04 | 224.27K |
| Q2 2017 | share | Decrease | -1.45% | -3.04K shares | 3.71M | $128.87 | 207.34K |
| Q1 2017 | share | Decrease | -10.72% | -25.25K shares | 5.64M | $109.35 | 210.39K |
| Q4 2016 | share | Decrease | -10.77% | -28.44K shares | -5.67M | $73.67 | 235.64K |
| Q3 2016 | share | Increase | +0.11% | 280 shares | 339K | $87.21 | 264.09K |
| Q2 2016 | share | Decrease | -8.30% | -23.86K shares | -175K | $86.02 | 263.81K |
| Q1 2016 | share | Increase | +15.24% | 38.05K shares | -8.54M | $79.49 | 287.68K |